Risk and Outcomes of Hospitalizations in Patients with Anti-Phospholipid Syndrome Admitted with Autoimmune Hemolytic Anemia: A Nation-Wide Analysis

Authors

Amir Mahmoud, Rochester Regional HealthFollow
Abdullah A. Orakzai, Rochester Regional HealthFollow
Tripti Jain, Rochester Regional HealthFollow
Himal Kharel, Rochester Regional HealthFollow
Arnav Srivastava, Rochester Regional HealthFollow
Niraj Neupane, Rochester Regional HealthFollow
Heba Yassin
Basant Eltaher, Rochester Regional HealthFollow
Ali Abdelhay, Rochester Regional HealthFollow

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Blood

Conference Name

ASH Annual Meeting

Conference Date

2023-12-09 - 2023-12-12

First Page

5516

DOI

10.1182/blood-2023-191046

Volume

142

Issue

Supplement 1

Publication Date

11-2-2023

Recommended Citation

Mahmoud, A., Orakzai, A. A., Jain, T., Kharel, H., Srivastava, A., Neupane, N., Yassin, H., Eltaher, B., & Abdelhay, A. (2023). Risk and Outcomes of Hospitalizations in Patients with Anti-Phospholipid Syndrome Admitted with Autoimmune Hemolytic Anemia: A Nation-Wide Analysis. Blood, 142 (Supplement 1), 5516. https://doi.org/10.1182/blood-2023-191046